Template:Ergotamine: Difference between revisions
Jump to navigation
Jump to search
(Blanked the page) |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ergotamine|{{fontcolor|#6C7B8B|Ergotamine}}]]''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ERGOMAR (ergotamine tartrate) tablet<sup>®</sup> FDA Package Insert | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet indications and usage|Indications and Usage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet dosage and administration|Dosage and Administration]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet dosage forms and strengths|Dosage Forms and Strengths]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet contraindications|Contraindications]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet warnings and precautions|Warnings and Precautions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet adverse reactions|Adverse Reactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet drug interactions|Drug Interactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet use in specific populations|Use in Specific Populations]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet overdosage|Overdosage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet description|Description]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet clinical pharmacology|Clinical Pharmacology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet nonclinical toxicology|Nonclinical Toxicology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet clinical studies|Clinical Studies]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet how supplied storage and handling|How Supplied/Storage and Handling]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet patient counseling information|Patient Counseling Information]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet labels and packages|Labels and Packages]] | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Medihaler ergotamine (ergotamine tartrate) aerosol, metered<sup>®</sup> FDA Package Insert | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered indications and usage|Indications and Usage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered dosage and administration|Dosage and Administration]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered dosage forms and strengths|Dosage Forms and Strengths]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered contraindications|Contraindications]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered warnings and precautions|Warnings and Precautions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered adverse reactions|Adverse Reactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered drug interactions|Drug Interactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered use in specific populations|Use in Specific Populations]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered overdosage|Overdosage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered description|Description]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered clinical pharmacology|Clinical Pharmacology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered nonclinical toxicology|Nonclinical Toxicology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered clinical studies|Clinical Studies]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered how supplied storage and handling|How Supplied/Storage and Handling]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered patient counseling information|Patient Counseling Information]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate) aerosol, metered labels and packages|Labels and Packages]] | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Medihaler ergotamine (ergotamine tartrate) aerosol, metered | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | |||
|- | |||
|} | |||
Latest revision as of 22:59, 11 February 2014
| Ergotamine |
|---|
| ERGOMAR (ergotamine tartrate) tablet® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Medihaler ergotamine (ergotamine tartrate) aerosol, metered® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Medihaler ergotamine (ergotamine tartrate) aerosol, metered |
| ClinicalTrials.gov |